Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials

EWER K.

Type

Journal article

Journal

Clinical and Experimental Immunology

Publisher

Wiley

Publication Date

06/01/2023

Permalink